Clinical Trial Update: Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating superficial basal cell carcinoma treated with photodynamic therapy using three photosensitizers (HAL, BF-200 ALA, and MAL).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Basal Cell Neoplasms

Drugs mentioned

• BF-200 ALA (5-aminolevulinic acid (ALA) topical photosensitizer)
• HAL (hexaminolevulinate)
• MAL (methyl aminolevulinate)

Snippet

Sponsor: Joint Authority for Päijät-Häme Social and Health Care | Conditions: Neoplasms, Basal Cell, Carcinoma, Basal Cell | Phase 1, Phase 2 | Status: UNKNOWN